Published in PLoS One on November 10, 2010
Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation. Nat Neurosci (2014) 1.49
The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. PLoS Genet (2012) 1.06
Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease. Dis Model Mech (2011) 1.00
Evaluating Drosophila p53 as a model system for studying cancer mutations. J Biol Chem (2012) 0.82
Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms. PLoS One (2013) 0.81
Inhibitory effects of magnolol and honokiol on human calcitonin aggregation. Sci Rep (2015) 0.80
Role of p53 isoforms and aggregations in cancer. Medicine (Baltimore) (2016) 0.79
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD). J Biol Chem (2013) 0.79
Possible alterations in β-Synuclein, the non-amyloidogenic homologue of α-Synuclein, during progression of sporadic α-synucleinopathies. Int J Mol Sci (2012) 0.77
Novel therapeutic approaches in multiple system atrophy. Clin Auton Res (2014) 0.76
A novel, sensitive assay for behavioral defects in Parkinson's disease model Drosophila. Parkinsons Dis (2012) 0.75
Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies. Biomolecules (2015) 0.75
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
A Drosophila model of Parkinson's disease. Nature (2000) 7.82
A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun (1980) 6.64
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry (1996) 6.47
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science (2000) 6.28
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A (2000) 5.83
Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem (1998) 5.81
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A (1999) 5.75
Folding proteins in fatal ways. Nature (2003) 5.58
Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci (2001) 4.92
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci (2002) 4.27
Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci (2005) 3.93
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A (2000) 3.86
Parkinson's disease. Hum Mol Genet (2007) 3.84
A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature (2006) 3.76
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1993) 3.73
Review: history of the amyloid fibril. J Struct Biol (2000) 3.49
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem (2007) 3.42
A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J (2002) 3.34
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol (2005) 3.18
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci (2002) 2.93
Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol (2002) 2.92
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol (2008) 2.78
Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J (2003) 2.64
Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem (2002) 2.07
alpha-Synuclein and neuronal cell death. Mol Neurodegener (2009) 1.85
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A (2002) 1.80
Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem (2002) 1.76
Getting out of shape. Nature (2002) 1.71
Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov (2002) 1.63
Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry (2004) 1.60
Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta (2008) 1.51
Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport (1999) 1.49
Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J Mol Biol (2006) 1.47
Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry (2000) 1.45
The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry (2003) 1.39
Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry (2003) 1.36
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J (2007) 1.35
Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem (2000) 1.35
The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry (2003) 1.30
Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide. Proc Natl Acad Sci U S A (2005) 1.28
15N-labeled Escherichia coli tRNAfMet, tRNAGlu, tRNATyr, and tRNAPhe. Double resonance and two-dimensional NMR of N1-labeled pseudouridine. J Biol Chem (1985) 1.27
Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation. J Mol Biol (2007) 1.21
Amyloid peptides and proteins in review. Rev Physiol Biochem Pharmacol (2007) 1.21
A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB J (2004) 1.07
Aberrant protein deposition and neurological disease. J Biol Chem (1999) 1.00
Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide. Biochem J (1995) 0.99
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Neurosci Lett (2006) 0.86
Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders? J Mol Neurosci (2004) 0.80
Casting metal nanowires within discrete self-assembled peptide nanotubes. Science (2003) 3.59
Commensal bacteria play a role in mating preference of Drosophila melanogaster. Proc Natl Acad Sci U S A (2010) 3.30
Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des (2006) 3.04
Controlled patterning of aligned self-assembled peptide nanotubes. Nat Nanotechnol (2006) 2.14
Amyloids: not only pathological agents but also ordered nanomaterials. Angew Chem Int Ed Engl (2008) 1.66
Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem (2002) 1.66
Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity. Cell (2010) 1.65
Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry (2004) 1.60
The YefM antitoxin defines a family of natively unfolded proteins: implications as a novel antibacterial target. J Biol Chem (2003) 1.56
QPath: a method for querying pathways in a protein-protein interaction network. BMC Bioinformatics (2006) 1.46
COP9 signalosome subunits 4 and 5 regulate multiple pleiotropic pathways in Drosophila melanogaster. Development (2002) 1.43
Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder. Proc Natl Acad Sci U S A (2005) 1.43
Peptide-based hydrogel nanoparticles as effective drug delivery agents. Bioorg Med Chem (2013) 1.42
Self-assembled peptide nanotubes are uniquely rigid bioinspired supramolecular structures. Nano Lett (2005) 1.38
Extrachromosomal circular DNA of tandemly repeated genomic sequences in Drosophila. Genome Res (2003) 1.38
The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry (2003) 1.30
Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development. Proc Natl Acad Sci U S A (2002) 1.28
Strong piezoelectricity in bioinspired peptide nanotubes. ACS Nano (2010) 1.25
Novel electrochemical biosensing platform using self-assembled peptide nanotubes. Nano Lett (2005) 1.22
In vivo aggregation of a single enzyme limits growth of Escherichia coli at elevated temperatures. Mol Microbiol (2002) 1.22
Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol (2002) 1.21
Self-assembled arrays of peptide nanotubes by vapour deposition. Nat Nanotechnol (2009) 1.20
Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J Biol Chem (2002) 1.19
Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin. Angew Chem Int Ed Engl (2006) 1.17
The yefM-yoeB toxin-antitoxin systems of Escherichia coli and Streptococcus pneumoniae: functional and structural correlation. J Bacteriol (2006) 1.12
Drosophila JAB1/CSN5 acts in photoreceptor cells to induce glial cells. Neuron (2002) 1.12
Extrachromosomal circular DNA derived from tandemly repeated genomic sequences in plants. Plant J (2007) 1.11
Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. Angew Chem Int Ed Engl (2004) 1.10
Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS One (2010) 1.06
Elementary building blocks of self-assembled peptide nanotubes. J Am Chem Soc (2010) 1.06
Thermal and chemical stability of diphenylalanine peptide nanotubes: implications for nanotechnological applications. Langmuir (2006) 1.06
Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs. Structure (2004) 1.05
Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. Nat Chem Biol (2012) 1.05
Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP. J Neurochem (2008) 1.04
Genomic analysis of COP9 signalosome function in Drosophila melanogaster reveals a role in temporal regulation of gene expression. Mol Syst Biol (2007) 1.04
Structural and thermodynamic characterization of the Escherichia coli RelBE toxin-antitoxin system: indication for a functional role of differential stability. Biochemistry (2007) 1.04
Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies. Angew Chem Int Ed Engl (2009) 1.03
Fabrication of coaxial metal nanocables using a self-assembled peptide nanotube scaffold. Nano Lett (2006) 1.02
Extrachromosomal circles of satellite repeats and 5S ribosomal DNA in human cells. Mob DNA (2010) 1.01
The physical properties of supramolecular peptide assemblies: from building block association to technological applications. Chem Soc Rev (2014) 1.01
Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry (2006) 1.01
Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PLoS One (2011) 1.01
The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats. J Mol Biol (2005) 1.00
Peptide nanotube-modified electrodes for enzyme-biosensor applications. Anal Chem (2005) 0.99
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J Med Chem (2008) 0.98
COP9 signalosome subunit 5 (CSN5/Jab1) regulates the development of the Drosophila immune system: effects on Cactus, Dorsal and hematopoiesis. Genes Cells (2007) 0.97
Blue luminescence based on quantum confinement at peptide nanotubes. Nano Lett (2009) 0.96
Peptide self-assembly at the nanoscale: a challenging target for computational and experimental biotechnology. Trends Biotechnol (2007) 0.95
Designed aromatic homo-dipeptides: formation of ordered nanostructures and potential nanotechnological applications. Phys Biol (2006) 0.95
The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J Biol Chem (2009) 0.94
The von Hippel-Lindau tumor suppressor protein is a molten globule under native conditions: implications for its physiological activities. J Biol Chem (2004) 0.94
Cop9 signalosome subunit 8 (CSN8) is essential for Drosophila development. Genes Cells (2008) 0.94
EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity. Biochem J (2011) 0.92
Self-assembly of phenylalanine oligopeptides: insights from experiments and simulations. Biophys J (2009) 0.92
The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain. FEBS J (2006) 0.91
Expanding the solvent chemical space for self-assembly of dipeptide nanostructures. ACS Nano (2014) 0.91
Evidence for rolling circle replication of tandem genes in Drosophila. Nucleic Acids Res (2005) 0.91
Quantum confinement in self-assembled bioinspired peptide hydrogels. Adv Mater (2010) 0.91
The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state. Protein Eng Des Sel (2009) 0.91
Stanniocalcin-1 secretion and receptor regulation in kidney cells. Am J Physiol Renal Physiol (2008) 0.90
Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water. Proteins (2005) 0.90
Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Proc Natl Acad Sci U S A (2008) 0.90
Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments. Amyloid (2004) 0.90
Controlled patterning of peptide nanotubes and nanospheres using inkjet printing technology. J Pept Sci (2008) 0.90
Drosophila Past1 is involved in endocytosis and is required for germline development and survival of the adult fly. J Cell Sci (2009) 0.89
Vertically aligned peptide nanostructures using plasma-enhanced chemical vapor deposition. Biomacromolecules (2014) 0.89
Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers (2008) 0.89
Design of metal-binding sites onto self-assembled peptide fibrils. Biopolymers (2009) 0.88
A model for the role of short self-assembled peptides in the very early stages of the origin of life. FASEB J (2005) 0.88
Symbiotic bacteria are responsible for diet-induced mating preference in Drosophila melanogaster, providing support for the hologenome concept of evolution. Gut Microbes (2011) 0.87
Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS. Biochim Biophys Acta (2008) 0.87
Self-assembled Fmoc-peptides as a platform for the formation of nanostructures and hydrogels. Biomacromolecules (2009) 0.86
Self-assembled organic nanostructures with metallic-like stiffness. Angew Chem Int Ed Engl (2010) 0.86
The structural basis of amyloid formation. Curr Alzheimer Res (2008) 0.85
Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. J Med Chem (2007) 0.85
Characterization of peptide-nanostructure-modified electrodes and their application for ultrasensitive environmental monitoring. Small (2010) 0.85
Genetic engineering of biomolecular scaffolds for the fabrication of organic and metallic nanowires. Angew Chem Int Ed Engl (2010) 0.85
Completely different amyloidogenic potential of nearly identical peptide fragments. Biopolymers (2003) 0.85
Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: implications for the modulation of amyloid self-assembly. Biochemistry (2008) 0.85
Unfolded protein response in Gaucher disease: from human to Drosophila. Orphanet J Rare Dis (2013) 0.85
Direct observation of the release of phenylalanine from diphenylalanine nanotubes. J Am Chem Soc (2006) 0.84
Structural disorder in the HIV-1 Vif protein and interaction-dependent gain of structure. Protein Pept Lett (2010) 0.83
Positively charged peptides can interact with each other, as revealed by solid phase binding assays. Anal Biochem (2006) 0.83
Transcriptional regulation by CHIP/LDB complexes. PLoS Genet (2010) 0.83
The YoeB toxin is a folded protein that forms a physical complex with the unfolded YefM antitoxin. Implications for a structural-based differential stability of toxin-antitoxin systems. J Biol Chem (2005) 0.83
The molecular mechanisms of the anti-amyloid effects of phenols. Amyloid (2007) 0.83
Crystallization of Doc and the Phd-Doc toxin-antitoxin complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.83
Bioinspired design of nanocages by self-assembling triskelion peptide elements. Angew Chem Int Ed Engl (2007) 0.82
The preferred conformation of the tripeptide Ala-Phe-Ala in water is an inverse gamma-turn: implications for protein folding and drug design. Biochemistry (2005) 0.82
Biological and chemical decoration of peptide nanostructures via biotin-avidin interactions. J Nanosci Nanotechnol (2007) 0.82
Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract. Biochim Biophys Acta (2012) 0.82